<DOC>
	<DOC>NCT00215358</DOC>
	<brief_summary>The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control drug.</brief_summary>
	<brief_title>Study in Patients With Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<criteria>Require regular use of an inhaled Beta2selective adrenergic agent Active acute or chronic disorders of the respiratory system within one month prior to screening Smoking history within the past 12 months or greater than a lifetime 10 packyear smoking history Recent surgical interventions such as lung lobectomy or resection (&lt; one year), or cardiothoracic interventions Lifethreatening systemic and debilitating diseases.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Formoterol</keyword>
	<keyword>Fumarate</keyword>
	<keyword>Foradil</keyword>
</DOC>